SHL Telemedicine Ltd. (SHLT)
USD 2.05
(0.99%)
USD 2.05
(0.99%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -9 Million USD | -31.45% |
| 2022 | -5.16 Million USD | -939.44% |
| 2021 | -497 Thousand USD | -225.51% |
| 2020 | 396 Thousand USD | -91.7% |
| 2019 | 4.77 Million USD | -60.19% |
| 2018 | 11.98 Million USD | 192.37% |
| 2017 | 4.1 Million USD | 185.56% |
| 2016 | -4.79 Million USD | 68.86% |
| 2015 | -15.38 Million USD | -1296.66% |
| 2014 | 1.28 Million USD | -58.49% |
| 2013 | 3.09 Million USD | 154.79% |
| 2012 | -5.65 Million USD | -235.52% |
| 2011 | 4.17 Million USD | -30.28% |
| 2010 | 5.98 Million USD | -10.03% |
| 2009 | 6.65 Million USD | 56.79% |
| 2008 | 4.24 Million USD | 141.82% |
| 2007 | -10.14 Million USD | -3425.9% |
| 2006 | 305 Thousand USD | 107.41% |
| 2005 | -4.11 Million USD | -140.93% |
| 2004 | -1.7 Million USD | -155.64% |
| 2003 | 3.07 Million USD | -73.66% |
| 2002 | 11.65 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -1.96 Million USD | 13.92% |
| 2024 Q2 | -1.96 Million USD | 0.0% |
| 2023 Q1 | -2.22 Million USD | 41.5% |
| 2023 Q3 | -1.66 Million USD | 57.22% |
| 2023 Q2 | -3.88 Million USD | -74.45% |
| 2023 Q4 | -2.27 Million USD | -37.19% |
| 2023 FY | -6.79 Million USD | -31.45% |
| 2022 Q2 | -922.2 Thousand USD | -81.36% |
| 2022 Q3 | -2.07 Million USD | -124.95% |
| 2022 FY | -5.16 Million USD | -939.44% |
| 2022 Q4 | -3.8 Million USD | -83.33% |
| 2022 Q1 | -508.49 Thousand USD | -400.89% |
| 2021 FY | -497 Thousand USD | -225.51% |
| 2021 Q2 | -63.5 Thousand USD | 0.0% |
| 2021 Q1 | -63.5 Thousand USD | -36.94% |
| 2021 Q3 | 169 Thousand USD | 366.14% |
| 2021 Q4 | 169 Thousand USD | 0.0% |
| 2020 Q2 | 996.49 Thousand USD | 390.88% |
| 2020 Q3 | 19 Thousand USD | -98.09% |
| 2020 FY | 396 Thousand USD | -91.7% |
| 2020 Q4 | -46.37 Thousand USD | -344.05% |
| 2020 Q1 | 203 Thousand USD | -85.79% |
| 2019 Q2 | 4.3 Million USD | 105.45% |
| 2019 Q1 | 2.09 Million USD | 37.39% |
| 2019 Q3 | 764.5 Thousand USD | -82.22% |
| 2019 FY | 4.77 Million USD | -60.19% |
| 2019 Q4 | 1.42 Million USD | 86.81% |
| 2018 Q4 | 1.52 Million USD | 112.62% |
| 2018 Q2 | 10.27 Million USD | 99.21% |
| 2018 Q1 | 5.15 Million USD | 566.56% |
| 2018 FY | 11.98 Million USD | 192.37% |
| 2018 Q3 | 716.5 Thousand USD | -93.02% |
| 2017 Q1 | 1.7 Million USD | 60.22% |
| 2017 FY | 4.1 Million USD | 185.56% |
| 2017 Q4 | -1.1 Million USD | 0.0% |
| 2017 Q3 | -1.1 Million USD | -164.79% |
| 2017 Q2 | 1.7 Million USD | 0.0% |
| 2016 Q3 | 1.06 Million USD | 168.35% |
| 2016 Q1 | -1.55 Million USD | 61.92% |
| 2016 Q2 | -1.55 Million USD | 0.0% |
| 2016 FY | -4.79 Million USD | 68.86% |
| 2016 Q4 | 1.06 Million USD | 0.0% |
| 2015 FY | -15.38 Million USD | -1296.66% |
| 2015 Q4 | -4.09 Million USD | 0.0% |
| 2015 Q3 | -4.09 Million USD | -664.58% |
| 2015 Q2 | -535 Thousand USD | -140.35% |
| 2015 Q1 | 1.32 Million USD | 141.53% |
| 2014 FY | 1.28 Million USD | -58.49% |
| 2014 Q1 | 366 Thousand USD | -88.38% |
| 2014 Q2 | 207 Thousand USD | -43.44% |
| 2014 Q3 | 164 Thousand USD | -20.77% |
| 2014 Q4 | 549 Thousand USD | 234.76% |
| 2013 FY | 3.09 Million USD | 154.79% |
| 2013 Q4 | 3.15 Million USD | 595.28% |
| 2013 Q3 | -636 Thousand USD | -256.65% |
| 2013 Q2 | 406 Thousand USD | 128.09% |
| 2013 Q1 | 178 Thousand USD | 104.93% |
| 2012 Q3 | -763 Thousand USD | -17.75% |
| 2012 FY | -5.65 Million USD | -235.52% |
| 2012 Q4 | -3.6 Million USD | -372.74% |
| 2012 Q1 | -636 Thousand USD | -359.59% |
| 2012 Q2 | -648 Thousand USD | -1.89% |
| 2011 FY | 4.17 Million USD | -30.28% |
| 2011 Q4 | 245 Thousand USD | -77.4% |
| 2011 Q3 | 1.08 Million USD | -25.4% |
| 2011 Q1 | 1.39 Million USD | -3.67% |
| 2011 Q2 | 1.45 Million USD | 4.53% |
| 2010 Q1 | 1.72 Million USD | 12.52% |
| 2010 Q4 | 1.44 Million USD | 10.24% |
| 2010 Q3 | 1.3 Million USD | -13.14% |
| 2010 FY | 5.98 Million USD | -10.03% |
| 2010 Q2 | 1.5 Million USD | -12.64% |
| 2009 Q4 | 1.53 Million USD | -17.62% |
| 2009 FY | 6.65 Million USD | 56.79% |
| 2009 Q3 | 1.86 Million USD | 5.02% |
| 2009 Q2 | 1.77 Million USD | 19.33% |
| 2009 Q1 | 1.48 Million USD | 0.0% |
| 2008 Q2 | 994 Thousand USD | 0.0% |
| 2008 FY | 4.24 Million USD | 141.82% |
| 2007 FY | -10.14 Million USD | -3425.9% |
| 2006 FY | 305 Thousand USD | 107.41% |
| 2005 FY | -4.11 Million USD | -140.93% |
| 2004 FY | -1.7 Million USD | -155.64% |
| 2003 FY | 3.07 Million USD | -73.66% |
| 2002 FY | 11.65 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| CareCloud, Inc. | -47.11 Million USD | 80.885% |
| Augmedix, Inc. | -18.77 Million USD | 52.042% |
| BrightSpring Health Services, Inc. Common Stock | 147.18 Million USD | 106.119% |
| CareCloud, Inc. | -47.11 Million USD | 80.885% |
| HealthEquity, Inc. | 128.13 Million USD | 107.029% |
| iCoreConnect Inc. | -10.27 Million USD | 12.364% |
| Inovalon Holdings, Inc. | 71.71 Million USD | 112.559% |
| Nutex Health, Inc. | -31.77 Million USD | 71.656% |
| Omnicell, Inc. | -34.86 Million USD | 74.171% |
| OneMedNet Corporation | -8.37 Million USD | -7.544% |
| Progyny, Inc. | 62.18 Million USD | 114.483% |
| Renalytix Plc | -29.6 Million USD | 69.583% |
| Schrödinger, Inc. | -177.44 Million USD | 94.925% |
| Simulations Plus, Inc. | 6.13 Million USD | 246.893% |
| SOPHiA GENETICS SA | -74.82 Million USD | 87.964% |
| Streamline Health Solutions, Inc. | -19.64 Million USD | 54.161% |
| Ontrak, Inc. | -20.67 Million USD | 56.44% |
| GE HealthCare Technologies Inc. | 2.43 Billion USD | 100.37% |
| Sharecare, Inc. | -96.47 Million USD | 90.665% |
| Aclarion, Inc. | -4.87 Million USD | -84.701% |
| CareMax, Inc. | -656.15 Million USD | 98.627% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.36 Million USD | -67.787% |
| Forian Inc. | -5.59 Million USD | -60.965% |
| Bullfrog AI Holdings, Inc. Warrants | -5.36 Million USD | -67.787% |
| HeartBeam, Inc. | -15.31 Million USD | 41.191% |
| GeneDx Holdings Corp. | -163.66 Million USD | 94.497% |
| SCWorx Corp. | -1.45 Million USD | -520.82% |
| Minerva Surgical, Inc. | -30.89 Million USD | 70.853% |
| Definitive Healthcare Corp. | -329.8 Million USD | 97.269% |
| 10x Genomics, Inc. | -265.32 Million USD | 96.606% |
| Zhongchao Inc. | -13.28 Million USD | 32.203% |
| Accolade, Inc. | -114.45 Million USD | 92.131% |
| MSP Recovery, Inc. | -559.87 Million USD | 98.391% |
| R1 RCM Inc. | 147.9 Million USD | 106.089% |
| Spok Holdings, Inc. | 21.22 Million USD | 142.425% |
| Privia Health Group, Inc. | 20.64 Million USD | 143.615% |
| EUDA Health Holdings Limited | -3.96 Million USD | -127.364% |
| TruBridge, Inc. | -42.6 Million USD | 78.861% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 147.18 Million USD | 106.119% |
| Sharecare, Inc. | -96.47 Million USD | 90.665% |
| Health Catalyst, Inc. | -126.89 Million USD | 92.903% |
| GoodRx Holdings, Inc. | -27 Million USD | 66.653% |
| Premier, Inc. | 157.08 Million USD | 105.733% |
| HealthStream, Inc. | 16.01 Million USD | 156.221% |
| Certara, Inc. | -40.77 Million USD | 77.912% |
| GeneDx Holdings Corp. | -163.66 Million USD | 94.497% |
| Ontrak, Inc. | -20.67 Million USD | 56.44% |
| CareCloud, Inc. | -47.11 Million USD | 80.885% |
| EUDA Health Holdings Limited | -3.96 Million USD | -127.364% |
| HeartBeam, Inc. | -15.31 Million USD | 41.191% |
| Mangoceuticals, Inc. | -9.21 Million USD | 2.309% |
| CareMax, Inc. | -656.15 Million USD | 98.627% |
| Healthcare Triangle, Inc. | -11.34 Million USD | 20.638% |
| National Research Corporation | 40.04 Million USD | 122.49% |
| Aclarion, Inc. | -4.87 Million USD | -84.701% |
| OptimizeRx Corporation | -26.4 Million USD | 65.889% |